Department of Pharmaceutical Chemistry

Research output

Research output per year 2009 2021 2022 2023 2024 2025

• 69 Article
• 26 Abstract
• 19 Meeting Abstract
• 12 Review article
• 24 More
  • 12 Doctoral Thesis
  • 8 Chapter
  • 2 Poster
  • 2 Specialist article

Research output per year

Research output per year

Search results

• 2024

  HMG-CoA reductase deficiency results in disturbed fatty acid β-oxidation and accumulation of long-chain acylcarnitines in the mouse liver

  Dambrova, M., Gukalova, B., Ozola, M., Krims-Dāvis, K., Zvejniece, L. & Liepiņš, E., Jun 2024, In: FEBS Open Bio. 14, Suppl.2, p. 407-408 P-32-070.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

  • Beta Oxidation 100%
  • HMG-CoA Reductase 100%
  • Statin 75%
  • Knockout Mouse 50%
  • Mouse Model 25%
• 2023

  ANALYSIS OF SINGLE ACCUMULATED NUCLEOTIDE VARIANTS AND MUTATION RATE IN M. TUBERCULOSIS ISOLATE PAIRS USING THE WHOLE GENOME SEQUENCING APPROACH

  Sadovska, D., Vīksna, A., Ozere, I., Norvaiša, I. & Ranka, R., 2023, In: Medicina (Kaunas). 59, Suppl.2, p. 348 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

  • Whole Genome Sequencing 100%
  • Single-Nucleotide Polymorphism 100%
  • Mutation Rate 100%
  • Mycobacterium Tuberculosis 81%
  • Genotyping 9%

• ASSESSMENT OF RIFAMPICIN EXPOSURE IN LATVIAN PULMONARY TUBERCULOSIS PATIENTS IN THE CONTEXT WITH AADAC GENETIC POLYMORPHISMS

  Kivrāne, A., Ulanova, V., Grinberga, S., Sevostjanovs, E., Vīksna, A., Pole, I., Ozere, I., Bogdanova, I., Zolovs, M., Bandere, D. & Ranka, R., 2023, In: Medicina (Kaunas). 59, Suppl.2, p. 351

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

  • Genetic Polymorphism 100%
  • Haplotype 100%
  • Lung Tuberculosis 100%
  • Rifampicin 100%
  • Next Generation Sequencing 33%

• Evaluation of Dispensing Medication Errors in Pharmaceutical Practice among Direct Oral Anticoagulants Prescriptions

  Gavrilova, A., Zolovs, M., Šmits, D., Latkovskis, G. & Urtāne, I., 2023, In: Medicina (Kaunas). 59, Suppl.2, p. 473

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

• In vitro and ex vivo antibacterial effects of levofloxacin against Pasteurella multocida and Escherichia coli  isolated from rabbits

  Sitovs, A., Skadins, I., Purvina, S. & Bandere, D., Jun 2023, In: Journal of Veterinary Pharmacology and Therapeutics. 46, Suppl.1, p. 74-75 O95.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

  • Escherichia coli 100%
  • Pasteurella multocida 100%
  • Leporidae 100%
  • Intramuscular Injection 9%
  • Intramuscular Drug Administration 9%

• Meldonium increases functional capacity of patients with chronic right ventricular failure

  Kigitovica, D., Dzirnieks, K., Sablinskis, M., Lejnieks, A., Vilskersts, R. & Skride, A., 2023, In: Medicina (Kaunas). 59, Suppl.2, p. 212

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

• National trends in the use of state-reimbursed oral lipid-lowering medications in Latvia (2012-2021)

  Praskilevics, A., Urtane, I. & Latkovskis, G., Aug 2023, In: Atherosclerosis. 379, Suppl.1, p. S172

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

• Ultra-flexible lipid vesicles for transdermal delivery of the blueberry extract: preliminary results for anti-oxidant activity

  Hallan, S. S., Bārzdiņa, A., Brangule, A. & Bandere, D., 2023, In: European Cells and Materials conferences open access online periodical. 2, p. P17

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2022

  The sigma-1 receptor dynamics, monitored with super-resolution imaging microscopy

  Rinken, A., Vavers, E., Veiksina, S., Ligi, K., Zvejniece, L. & Kopanchuk, S., Aug 2022, In: Journal of Neurochemistry. 162, S1, p. 159 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• WGS-based approach in studying first-line antituberculosis drug resistance-associated mutations in different M. tuberculosis genotypes

  Freimane, L., Sadovska, D., Viksna, A., Pole, I., Ozere, I., Norvaisa, I. & Ranka, R., Jul 2022, In: FEBS Open Bio. 12, S1, p. 176 1 p.

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access
• 2020

  A case-control study of the association between genetic polymorphisms and the exudative age-related macular degeneration in Latvian population

  Baumane, B., Briede, E., Baumane, K., Igumnova, V. & Ranka, R., 2020, In: Medicina (Kaunas). 56, S1, p. 78

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

• Application of M. tuberculosis whole genome sequencing in cluster investigation and verification of infectious sources in children-related tuberculosis outbreak

  Ranka, R., Pole, I., Aļeiņikova, D., Ķimsis, J., Norvaiša, I., Kolosa, N. & Ozere, I., 2020, In: Medicina (Kaunas). 56, S1, p. 14

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access

• Insights on senescence and therapy-related adverse effects in tuberculosis patients

  Freimane, L., Zole, E., Barkāne, L. & Ranka, R., 2020, In: Medicina (Kaunas). 56, S1, p. 239

  Research output: Contribution to journal › Meeting Abstract › peer-review

  Open Access
• 2016

  Searching for novel serodiagnostic markers of Lyme borreliosis in Latvia

  Igumnova, V., Capligina, V., Petrovskis, I., Sondore, V., Bandere, D. & Ranka, R., Sept 2016, In: FEBS Journal. 283, S1, p. 147-148 P04011-008.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2015

  The causes of the lack of patient compliance during antihypertensive therapy from pharmacist's perspective

  Urtane, I., Spalva, K., Puke, K., Irbe, A., Meinerts, M., Duhanova, A., Berzina, S. & Bandere, D., Feb 2015, In: International Journal of Clinical Pharmacy. 37, 1, p. 210-210 CP-PC046.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2014

  COMPLIANCE-RELATED PROBLEMS OF MEDICINES IN THE PHARMACEUTICAL PRACTISE

  Urtane, I., Pukite, K., Berzina, S., Stokmane, A. S. & Bandere, D., Aug 2014, In: Atherosclerosis. 235, 2, p. E292-E292

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2012

  Influence of cyclooxygenase-1 polymorphisms on urinary 11-dehydrothromboxane B2 levels in patients undergoing stent implantation

  Urtane, I., Latkovskis, G., Licis, N., Krivmane, B., Liepins, E., Dambrova, M., Knipse, A., Zabunova, M., Berzina, M. & Erglis, A., Feb 2012, In: International Journal of Clinical Pharmacy. 34, 1, p. 254-255 PT-055.

  Research output: Contribution to journal › Meeting Abstract › peer-review
• 2009

  Characterization of mildronate as an inhibitor of carnitine acetyltransferase

  Kuka, J., Zinovjevs, K., Skapare, E. & Liepinsh, E., Jul 2009, In: FEBS Journal. 276, p. 322 P8-85.

  Research output: Contribution to journal › Meeting Abstract › peer-review

• The beneficial effects of inhibitor of L-carnitine biosynthesis in experimental rat model of type 2 diabetes

  Skapare, E., Vilskersts, R., Svalbe, B. & Dambrova, M., Jul 2009, In: FEBS Journal. 276, p. 344 P8-158.

  Research output: Contribution to journal › Meeting Abstract › peer-review